Depigmenting Potential Of Lichen Extracts Evaluated By in Vitro And in Vivo Tests Part 2

Apr 11, 2023

According to relevant studies,cistanche is a common herb that is known as "the miracle herb that prolongs life". Its main component is cistanoside, which has various effects such as antioxidant, anti-inflammatory, and immune function promotion. The mechanism between cistanche and skin whitening lies in the antioxidant effect of cistanche glycosides. Melanin in human skin is produced by the oxidation of tyrosine catalyzed by tyrosinase, and the oxidation reaction requires the participation of oxygen, so the oxygen-free radicals in the body become an important factor affecting melanin production. Cistanche contains cistanoside, which is an antioxidant and can reduce the generation of free radicals in the body, thus inhibiting melanin production.

cistanche chemist warehouse

In addition, cistanche also has the function of promoting collagen production, which can increase the elasticity and luster of the skin and help repair damaged skin cells. Cistanche Phenylethanol Glycosides have a significant down-regulating effect on tyrosinase activity, and the effect on tyrosinase is shown to be competitive and reversible inhibition, which can provide a scientific basis for developing and utilizing the whitening ingredients in Cistanche. Therefore, cistanche has a key role in skin whitening. It can inhibit melanin production to reduce discoloration and dullness; and promote collagen production to improve skin elasticity and radiance. Due to the widespread recognition of these effects of cistanche, many skin whitening products have begun to infuse herbal ingredients such as Cistanche to meet consumer demand, thus increasing the commercial value of Cistanche in skin whitening products. In summary, the role of cistanche in skin whitening is crucial. Its antioxidant effect and collagen-producing effect can reduce discoloration and dullness, improve skin elasticity and luster, and thus achieve a whitening effect. Also, the wide application of Cistanche in skin whitening products demonstrates that its role in commercial value cannot be underestimated.

cistanche nedir

Click on What to eat for whitening

For more info: 

david.deng@wecistanche.com  WhatApp:86 13632399501

Detection of tyrosinase inhibition by TLC bioautography

The TLC profile made it possible to show the main substances contained in each extract. Identification of these substances is not an aim of this work, but, as an example, the spot of vulpinic acid (yellow under visible light) in L. vulpina methanolic extract is evident (Huneck & Yoshimura, 1996) (Fig. 2). Bioautography data revealed that several compounds exert inhibitory effects on tyrosinase activity. Most notably, the inhibitory activity of C. islandica chloroform-methanol extract was distributed among different bands covering a wide range of polarity (Fig. 2A). Conversely, the tyrosinase inhibitory activity of L. vulpina methanol extract is concentrated in one band that migrates close to the large yellow band corresponding to vulpinic acid (Fig. 2B).

Lichen extract depigmenting effects on MeWO cells

The MeWo human melanoma cell line was used as an in vitro model to explore lichen depigmenting effects. As a first step, cells were subjected to cell viability assay upon exposure for 48 h to increasing concentrations of L. vulpina methanol and C. islandica chloroform-methanol extracts. Dose–response curves of cell viability allowed deriving IC50 values of 88 µg/ml (95% CI [68–113 µg/ml]) for L. vulpina and 264 µg/ml (95% CI [213–328 µg/ml]) for C. islandica. Threshold IC05 values were 19 µg/ml (95% CI [9–40 µg/ml]) and 51 µg/ml (95% CI [31–85 µg/ml]), respectively.

where can i buy cistanche

Thereafter, the assay of melanin conducted on MeWo cells, after 72 h exposure to different lichen extract concentrations, showed a sharp reduction concerning controls induced by both extracts. In these experiments, arbutin (8 mM) was used as a positive control, reducing the melanin content of cells to about 50% of controls. The methanol extract of L. vulpina induced a melanin reduction similar to that of arbutin, occurring already at a concentration as low as 10 µg/ml (Fig. 3). This concentration is lower than the threshold for cytotoxic effects measured for this extract, allowing to rule out the possibility of specific injurious effects on cells. A similar effect on the melanin content of cells was also observed for the C. islandica chloroform-methanol extract, but only at a concentration of 50 µg/ml (Fig. 3). However, also the effective concentration of this extract was lower than the threshold for cytotoxic effects. 

Phenotype-based evaluation of depigmenting effects of lichen extracts using zebrafish 

Zebrafish models were used to further substantiate in vivo the effects of the inhibition of melanogenesis by C. islandica and L. vulpina. To define the optimal concentration to use, the first embryos were subjected to toxicity assay upon exposure for 48 h to increasing concentrations of L. vulpina methanol and C. islandica chloroform-methanol extracts. 

how to take cistanche

Thereafter, we observed that, when treated with subtoxic doses of C. islandica and L. vulpina, zebrafish larvae had a reduction in pigmentation (Figs. 4 and 5). The extract of L. vulpina showed higher inhibitory activity than C. islandica, as indicated by data from image analysis. Logistic regression curves yielded IC50 values of 44 µg/ml (42–47 µg/ml) for the chloroform-methanol extract of C. islandica, and 30 µg/ml (25–36 µg/ml) for the methanol extract of L. vulpina (Fig. 6). Finally, the depigmenting activity of C. islandica and L. vulpina extracts was also evaluated in the zebrafish embryos by melanin assay (Supplemental Information). 

cistanche side effects reddit

cistanche for sale

rou cong rong benefits

DISCUSSION

Our study highlighted a complex of in vitro and in vivo depigmenting effects due to specific lichens and extraction solvents. The strategy to choose separate extractions with a variety of solvent polarities, instead of a successive extraction with solvents of increasing polarities, was dictated by the pioneering aspect of the investigation. The study was aimed at disclosing widely available lichen species that could be exploited for their depigmenting effects, with a piece of very limited knowledge about the possible presence of active principles and their interactions. Therefore, we adopted an extract fractionation method that can involve some composition overlap among fractions but maximizes their depigmenting performance, possibly also due to synergistic effects. 

As for tyrosinase inhibition in cell-free experiments, our results confirm data from Higuchi et al. (1993), showing tyrosinase inhibition rates of 40.4% for L. vulpina and 13.8% for C. islandica, concerning our 86.2% and 42.6%, respectively, possibly due to the use of cultured lichens and different extraction solvent. We showed the strongest activity for the methanol extract of L. vulpina, followed by the chloroform-methanol extracts of C. islandica. Thus, these extracts were used to explore the anti-melanogenic activity of melanoma cells and zebrafish larvae. Data obtained from these tests confirmed those from cell-free experiments, and in all cases, the methanol extract of L. vulpina induced the strongest effect. 

In addition, bioautography assay indicates that different substances contained in these lichens exert tyrosinase inhibition. Although we did not perform a complete characterization of the extracts, we know from the literature the main lichen substances characterizing these lichens: L. vulpina contains atranorin and vulpinic acid, while C. islandica contains lichesterinic, protolichesterinic and fumarprotocetraric acid (Culberson, 1969). However, information regarding the antityrosinase activities of lichen substances in the literature is relatively poor, while only in a few cases it was possible to clarify the mechanisms of inhibition. Recently, Brandão et al. (2017) isolated fumarprotocetraric acid from the lichen Cladonia verticillate and showed uncompetitive, mixed-type inhibition on tyrosinase activity which rose with increasing concentration, at 0.6 mM the acid inhibited tyrosinase activity by 39.8%.

cistanche norge

An element that makes comparisons among different lichen species a difficult task is the high variability of chemical composition, which is also subjected to the variation of environmental parameters, habitat, and microclimatic characteristics (e.g., availability of water and light) (Matteucci et al., 2017). These differences may underlie considerable differences in the biological activity of lichen phytocomplexes in which the composition has not been quantitatively characterized. Therefore, further work is necessary to isolate and quantify active compounds from the extracts to better define the components with antityrosinase activity. So far, several works have investigated the possible antityrosinase activity of lichen compounds (e.g., Kwong et al., 2020; Honda et al., 2016; Lopes, Coelho & Honda, 2018). For example, Kim & Cho (2007) determined that methanolic extracts of Usnea longissima and Usnea esculent affected melanin formation independently from their antioxidant action. About their phenolic structure, different constituents are likely to be strong tyrosinase inhibitors, with a much lower IC50 concerning that of the whole extract. 

In conclusion, our study provides evidence of depigmenting effects of specific lichen extracts, going from tyrosinase inhibition in cell-free experiments to depigmenting effects in vitro on cultured cells and in vivo on zebrafish larvae. These data indicate that L. vulpina and C. islandica lichen extracts are potential candidates for developing pharmaceutical and cosmetic products for skin whitening. Moreover, data also suggest that L. vulpina could be a good source for the isolation of compounds with strong depigmenting properties. Future objectives in this direction will be the chemical characterization of the lichen extracts and the evaluation of the activity of their most promising constituents.

ADDITIONAL INFORMATION AND DECLARATIONS 

Funding 

This work was supported by the University of Genova (FRA2018). The funders had no role in the study design, data collection, analysis, the decision to publish, or the preparation of the manuscript. 

Grant Disclosures 

The following grant information was disclosed by the authors: University of Genova: FRA2018. 

Competing Interests 

Paolo Giordani is an Academic Editor for PeerJ.

Author Contributions

• Paola Malaspina and Lucia Caputo conceived and designed the experiments, performed the experiments, analyzed the data, prepared figures and/or tables, authored or reviewed drafts of the paper, and approved the final draft.
• Erica Catellani performed the experiments, prepared figures and/or tables, and approved the final draft.
• Bruno Burlando and Paolo Giordani conceived and designed the experiments, analyzed the data, authored or reviewed drafts of the paper, and approved the final draft.
• Daniele Brignole and Miriam Bazzicalupo performed the experiments, authored or reviewed drafts of the paper, and approved the final draft.
• Laura Cornara and Vincenzo De Feo conceived and designed the experiments, authored or reviewed drafts of the paper, and approved the final draft.
• Simona Candiani conceived and designed the experiments, analyzed the data, prepared figures and/or tables, authored or reviewed drafts of the paper, and approved the final draft.
• Valentina Obino performed the experiments, analyzed the data, prepared figures and/or tables, authored or reviewed drafts of the paper, and approved the final draft. 

Animal Ethics 

The following information was supplied relating to ethical approvals (i.e., approving body and any reference numbers): 

The experimental protocol was authorized by the University of Genova, General Business and Accounting Division (Protocol Number: 1280G 21/2/92) and the Ministry of Health, Directorate for Animal Health and Veterinary Drugs, Office VI (Project Number: 720/2015-PR). 

Data Availability

The following information was supplied regarding data availability:

The raw measurements of tyrosinase inhibition are available in a Supplemental File.

Supplemental Information 

Supplemental information for this article can be found online.

REFERENCES

1. Behera BC, Adawadkar B, Makhija U. 2004. The capacity of some Graphidaceous lichens to scavenge superoxide and inhibition of tyrosinase and xanthine oxidase activities. Current Science 87:83–87. 

2. Boustie J, Tomasi S, Grube M. 2011. Bioactive lichen metabolites: alpine habitats as an untapped source. Phytochemistry Reviews 10:287–307 

3. Brandão LFG, Da Silva Santos NP, Pereira ECG, Da Silva NH, Matos M de FC, Bogo D, Honda NK. 2017. Effects of fumarprotocetraric acid, a depsidone from the lichen cladonia verticillaris, on tyrosinase activity. Orbital - The Electronic Journal of Chemistry 9:256–260 

4. Cheli Y, Ohanna M, Ballotti R, Bertolotto C. 2010. Fifteen-year quest for microphthalmia-associated transcription factor target genes. Pigment Cell & Melanoma Research 23:27–40.

5. Cornara L, Pastorino G, Borghesi B, Salis A, Clericuzio M, Marchetti C, Damonte G, Burlando B. 2018. Posidonia oceanic (L.) defile ethanolic extract modulates cell activities with skin health applications. Marine Drugs 16:21. 

6. Crawford SD. 2015. Lichens used in traditional medicine, in Lichen secondary metabolites: bioactive properties and pharmaceutical potential. In: Branislav Rankovic. Basel: Springer International Publishing, 27–80. 

7. Culberson CF. 1969. Chemical and botanical guide to lichen products. Chapel Hill: The University of North Carolina Press. 

8. Culberson CF, Kristinsson H-D. 1970. A standardized method for the identification of lichen products. Journal of Chromatography A 46:85–93. 

9. Devkota S, Chaudhary RP, Werth S, Scheidegger C. 2017. Indigenous knowledge and use of lichens by the technophilic communities of the Nepal Himalaya. Journal of Ethnobiology and Ethnomedicine 13:15. 

10. D’Mello SAN, Finlay GJ, Baguley BC, Askarian-Amiri ME. 2016. Signaling pathways in melanogenesis. International Journal of Molecular Sciences 17(7):1144. 

11. Einarsdóttir E, Groeneweg J, Björnsdóttir GG, Harethardottir G, Omarsdóttir S, Ingólfsdóttir K, Ogmundsdóttir HM. 2010. Cellular mechanisms of the anti-cancer effects of the lichen compound usnic acid. Planta Medica 76:969–974. 

12. Gül¸cin I, Oktay M, Küfrevioğlu OI, Aslan A. 2002. Determination of the antioxidant activity of lichen Cetraria islandica (L) Ach. Journal of Ethnopharmacology 79:325–329. 

13.Higuchi M, Miura Y, Boohene J, Kinoshita Y, Yamamoto Y, Yoshimura I, Yamada Y. 1993. Inhibition of tyrosine activity by cultured lichen tissues and bits. Planta Medica 59:253–255. 

14. Honda NK, Gon¸calves K, Brandão LFG, Coelho RG, Micheletti AC, Spielmann AA, Canêz LS. 2016. Screening of lichen extracts using tyrosinase inhibition and toxicity against artemia salina. Orbital: The Electronic Journal of Chemistry 8:181–188–188. 

15. Huneck S, Yoshimura I. 1996. Identification of lichen substances. In: Identification of lichen substances. Berlin: Springer. 

16. Kim M-S, Cho H-B. 2007. Melanogenesis inhibitory effects of methanolic extracts of umbilical esculent and usnea longissima. Journal of Microbiology 45:578–582. 

17. Kondo T, Hearing VJ. 2011. Update on the regulation of mammalian melanocyte function and skin pigmentation. Expert Review of Dermatology 6:97–108. 

18. Kwong SP, Wang H, Shi L, Huang Z, Lu B, Cheng X, Chou G, Ji L, Wang C. 2020. Identification of photodegraded derivatives of usnic acid with improved toxicity profile and UVA/UVB protection in normal human L02 hepatocytes and epidermal melanocytes. Journal of Photochemistry and Photobiology B: Biology 205:111814. 

19. Leyden JJ, Shergill B, Micali G, Downie J, Wallo W. 2011. Natural options for the management of hyperpigmentation. Journal of the European Academy of Dermatology and Venereology 25:1140–1145.

20. Li W-J, Lin Y-C, Wu P-F, Wen Z-H, Liu P-L, Chen C-Y, Wang H-M. 2013. Biofunctional constituents from liriodendron tulipifera with antioxidants and anti-melanogenic properties. International Journal of Molecular Sciences 14:1698–1712.

21. Lin C-HV, Ding H-Y, Kuo S-Y, Chin L-W, Wu J-Y, Chang T-S. 2011. Evaluation of in vitro and in vivo depigmenting activity of raspberry ketone from Rheum officinale. International Journal of Molecular Sciences 12:4819–4835.

22. Lo C-Y, Liu P-L, Lin L-C, Chen Y-T, Hseu Y-C, Wen Z-H, Wang H-M. 2013. Antimelanoma and antityrosinase from Alpinia galangal constituents. The Scientific World Journal 2013:Article 186505. 

23. Lopes TIB, Coelho RG, Honda NK. 2018. Inhibition of mushroom tyrosinase activity by orsellinates. Chemical and Pharmaceutical Bulletin 66:61–64. 

24. Matteucci E, Occhipinti A, Piervittori R, Maffei ME, Favero-Longo SE. 2017. The morphological, secondary metabolite, and ITS (rDNA) variability within usnic acid-containing lichen thalli of xanthoparmelia explored at the local scale of rock outcrop in W-Alps. Chemistry & Biodiversity 14:e1600483. 

25. Muggia L, Schmitt I, Grube M. 2009. Lichens as treasure chests of natural products. SIM News 85–97. 

26. Mukherjee PK, Biswas R, Sharma A, Banerjee S, Biswas S, Katiyar CK. 2018. Validation of medicinal herbs for anti-tyrosinase potential. Journal of Herbal Medicine 14:1–16. 

27. Nash III TH. 2006. Lichen biology. Cambridge: Cambridge University Press. 

28. Parvez S, Kang M, Chung H-S, Bae H. 2007. Naturally occurring tyrosinase inhibitors: mechanism and applications in skin health, cosmetics, and agriculture industries. Phytotherapy Research 21:805–816. 

29. Pastorino G, Marchetti C, Borghesi B, Cornara L, Ribulla S, Burlando B. 2017. Biological activities of the legume crops Melilotus officinalis and Lespedeza capitata for skin care and pharmaceutical applications. Industrial Crops and Products 96:158–164. 

30. Phinney NH, Solhaug KA, Gauslaa Y. 2018. The rapid resurrection of chlorolichens in humid air: specific thallus mass drives rehydration and reactivation kinetics. Environmental and Experimental Botany 148:184–191. 

31. R Core Team. 2013. R: a language and environment for statistical computing. R Package Version 3.0.1. Vienna: R Foundation for Statistical Computing.

32. Ranković B, Kosanić M. 2015. Lichens as a potential source of bioactive secondary metabolites. In: Ranković B, ed. Lichen secondary metabolites. Cham: Springer International Publishing, 1–26. 

33. Solano F. 2014. Melanins: skin pigments and much more—types, structural models, biological functions, and formation routes. New Journal of Science 2014:1–28. 

34. Souza LF, Caputo L, Inchausti De Barros IB, Fratianni F, Nazzaro F, De Feo V. 2016. Pereskia aculeata Muller (Cactaceae) Leaves: chemical composition and biological activities. International Journal of Molecular Sciences 17(7):1478. 

35. Takayama A, Hata Y, Itakura K, Murase M, Shoji M, Ito M, Sasaki H. 2010. Skin-lightening agents, melanin formation inhibitors, and skin-lightening cosmetics containing cultures or extracts of specific lichens. Patent code: JP 2010150173 A 20100708. 

36. Wang H-M, Chou Y-T, Hong Z-L, Chen H-A, Chang Y-C, Yang W-L, Chang H-C, Mai C-T, Chen C-Y. 2011. Bioconstituents from stems of Synsepalum dulcificum Daniell (Sapotaceae) inhibit human melanoma proliferation, reduce mushroom tyrosinase activity, and have antioxidant properties. Journal of the Taiwan Institute of Chemical Engineers 2:204–211. 

37. Wangthong S, Tonsiripakdee I, Monhaphol T, Nonthabenjawan R, Wanichwecharun-gruang SP. 2007. Post TLC developing a technique for tyrosinase inhibitor detection. Biomedical Chromatography 21:94–100. 

38. White FJ, James PW. 1985. A new guide to microchemical techniques for the identification of lichen substances. In: British Lichen Society Bulletin. n. 57 (suppl.). London: British Lichen Society. 


For more info: david.deng@wecistanche.com  WhatApp:86 13632399501

You Might Also Like